Literature DB >> 22247362

Mortality profile related to systemic lupus erythematosus: a multiple cause-of-death analysis.

Deborah C C Souza1, Augusto H Santo, Emilia I Sato.   

Abstract

OBJECTIVE: To analyze the mortality profile related to systemic lupus erythematosus (SLE) in the state of São Paulo, Brazil.
METHODS: For the 1985-2007 period, we analyzed all death certificates (n = 4815) on which SLE was listed as an underlying (n = 3133) or non-underlying (n = 1682) cause of death. We evaluated sex, age, and the causes of death, comparing the first and last 5 years of the period, as well as determining the observed/expected death ratio (O/E ratio).
RESULTS: For SLE as an underlying cause, the mean age at death was 35.77 years (SD 15.12) and the main non-underlying causes of death were renal failure, circulatory system diseases, pneumonia, and septicemia. Over the period, the proportional mention of infectious causes and circulatory system diseases increased, whereas renal diseases decreased. For SLE as a non-underlying cause of death, the most common underlying causes of death were circulatory, respiratory, genitourinary, and digestive system diseases, and certain infections. The overall death O/E ratio was > 1 for renal failure, tuberculosis, septicemia, pneumonia, and digestive system diseases, as well as for circulatory system diseases at < 50 years of age, particularly acute myocardial infarct.
CONCLUSION: Unlike in developed countries, renal failure and infectious diseases are still the most frequent causes of death. The increase in SLE deaths associated with infection, especially pneumonia and septicemia, is worrisome. The judicious use of immunosuppressive therapy together with vigorous treatment of cardiovascular comorbidities is crucial to the successful management of SLE and to improving survival of patients with SLE.

Entities:  

Mesh:

Year:  2012        PMID: 22247362     DOI: 10.3899/jrheum.110241

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  20 in total

Review 1.  A review on SLE and malignancy.

Authors:  May Y Choi; Kelsey Flood; Sasha Bernatsky; Rosalind Ramsey-Goldman; Ann E Clarke
Journal:  Best Pract Res Clin Rheumatol       Date:  2017-11-10       Impact factor: 4.098

2.  Survival analysis of patients with systemic lupus erythematosus in a tertiary hospital in southern Brazil.

Authors:  Jordana Vaz Hendler; Lucian de Souza; Daniele Corrêa de Freitas Zernow; Juliano Guimarães; Thiago Bertotto; Carla Forgiarini Saldanha; João Carlos Tavares Brenol; Odirlei André Monticielo
Journal:  Clin Rheumatol       Date:  2017-06-26       Impact factor: 2.980

3.  Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years.

Authors:  Yunyun Fei; Xiaochun Shi; Fengying Gan; Xuemei Li; Wen Zhang; Mengtao Li; Yong Hou; Xuan Zhang; Yan Zhao; Xiaofeng Zeng; Fengchun Zhang
Journal:  Clin Rheumatol       Date:  2013-09-18       Impact factor: 2.980

4.  Impact of Sex on Systemic Lupus Erythematosus-Related Causes of Premature Mortality in the United States.

Authors:  Titilola Falasinnu; Yashaar Chaichian; Julia F Simard
Journal:  J Womens Health (Larchmt)       Date:  2017-09-11       Impact factor: 2.681

5.  Allelic heterogeneity in NCF2 associated with systemic lupus erythematosus (SLE) susceptibility across four ethnic populations.

Authors:  Xana Kim-Howard; Celi Sun; Julio E Molineros; Amit K Maiti; Hema Chandru; Adam Adler; Graham B Wiley; Kenneth M Kaufman; Leah Kottyan; Joel M Guthridge; Astrid Rasmussen; Jennifer Kelly; Elena Sánchez; Prithvi Raj; Quan-Zhen Li; So-Young Bang; Hye-Soon Lee; Tae-Hwan Kim; Young Mo Kang; Chang-Hee Suh; Won Tae Chung; Yong-Beom Park; Jung-Yoon Choe; Seung Cheol Shim; Shin-Seok Lee; Bok-Ghee Han; Nancy J Olsen; David R Karp; Kathy Moser; Bernardo A Pons-Estel; Edward K Wakeland; Judith A James; John B Harley; Sang-Cheol Bae; Patrick M Gaffney; Marta Alarcón-Riquelme; Loren L Looger; Swapan K Nath
Journal:  Hum Mol Genet       Date:  2013-10-26       Impact factor: 6.150

Review 6.  Cardiovascular disease in lupus: insights and updates.

Authors:  Jason S Knight; Mariana J Kaplan
Journal:  Curr Opin Rheumatol       Date:  2013-09       Impact factor: 5.006

7.  Hyposalivation in autoimmune diseases.

Authors:  Etsuko Maeshima; Kanako Furukawa; Shinichiro Maeshima; Hiroya Koshiba; Wataru Sakamoto
Journal:  Rheumatol Int       Date:  2012-12-29       Impact factor: 2.631

8.  Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review.

Authors:  Jenny Amaya-Amaya; Juan Camilo Sarmiento-Monroy; Julián Caro-Moreno; Nicolás Molano-González; Rubén D Mantilla; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Autoimmune Dis       Date:  2013-11-03

9.  Risk of epilepsy in patients with systemic lupus erythematosus - a retrospective cohort study.

Authors:  Jeng-Dau Tsai; Cheng-Li Lin; Cheng-Chieh Lin; Fung-Chang Sung; Ko-Huang Lue
Journal:  Neuropsychiatr Dis Treat       Date:  2014-09-02       Impact factor: 2.570

10.  Clinical features and mortality in Chinese with lupus nephritis and neuropsychiatric lupus: A 124-patient study.

Authors:  Min Feng; Jun Lv; Sha Fu; Bo Liu; Ying Tang; Xia Wan; Peifen Liang; Yuchun Zeng; Jingao Li; Yanying Lu; Xiaomei Li; Anping Xu
Journal:  J Res Med Sci       Date:  2014-05       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.